Cell Therapeutics, Ortho Biotech Inc., R. W. Johnson Pharmaceuticals Research Institute deal

Cell Therapeutics will collaborate with the two Johnson & Johnson subsidiaries to complete development of lisofylline, an inhibitor of phosphatidic acid,

Read the full 218 word article

How to gain access

Continue reading with a
two-week free trial.